Beta HCG (Oncology)

Tumor markers are usually glycoproteins (soluble molecules) in the blood, which can be detected by monoclonal antibodies. Highly raised levels of a tumor marker can provide helpful information but inappropriate use can have economic implications and cause patients additional anxiety and distress. Additionally, unnecessary investigations may be associated with side-effects and may delay correct diagnosis and treatment

Each tumor marker has a variable profile of uses.

Used to detect Nonseminomatous germ cell tumors, gestational trophoblastic disease.

Screening tests require high sensitivity to detect early-stage disease.